China Shineway Pharmaceutical Group (HKSE:02877) Scaled Net Operating Assets : 0.15 (As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is China Shineway Pharmaceutical Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

China Shineway Pharmaceutical Group's operating assets for the quarter that ended in Jun. 2024 was HK$3,929 Mil. China Shineway Pharmaceutical Group's operating liabilities for the quarter that ended in Jun. 2024 was HK$2,365 Mil. China Shineway Pharmaceutical Group's Total Assets for the quarter that ended in Dec. 2023 was HK$10,472 Mil. Therefore, China Shineway Pharmaceutical Group's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.15.

China Shineway Pharmaceutical Group Scaled Net Operating Assets Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Scaled Net Operating Assets Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.33

0.34

0.25

0.17

China Shineway Pharmaceutical Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.22	0.17	0.19	0.16	0.15

Competitive Comparison of China Shineway Pharmaceutical Group's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Shineway Pharmaceutical Group's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Scaled Net Operating Assets falls into.

China Shineway Pharmaceutical Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

China Shineway Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(4008.937	-	2447.767)	/	9192.64
=	0.17

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10471.831	-	6462.894
=	4008.937

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2777.351	-	0.388	-	329.196
=	2447.767

China Shineway Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(3928.718	-	2365.032)	/	10471.831
=	0.15

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10640.939	-	6712.221
=	3928.718

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2742.959	-	13.324	-	364.603
=	2365.032

China Shineway Pharmaceutical Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. It is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

Executives

Bh Corporate Services Ltd	2301 Trustee
Bodnar-horvath Kwai Yung Helen	2202 Interest of your spouse
Bodnar-horvath Nicholas Eugene Francis	2201 Interest of corporation controlled by you
Forway Investment Limited	2101 Beneficial owner
Li Zhenjiang	2307 Founder of a discretionary trust who can infl

China Shineway Pharmaceutical Group Headlines

No Headlines